chr19-2191212-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -15 ACMG points: 0P and 15B. BP4_ModerateBP6_Very_StrongBP7BS2
The NM_032482.3(DOT1L):c.465C>T(p.Asp155=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000744 in 1,613,910 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0038 ( 4 hom., cov: 31)
Exomes 𝑓: 0.00043 ( 5 hom. )
Consequence
DOT1L
NM_032482.3 synonymous
NM_032482.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.937
Genes affected
DOT1L (HGNC:24948): (DOT1 like histone lysine methyltransferase) The protein encoded by this gene is a histone methyltransferase that methylates lysine-79 of histone H3. It is inactive against free core histones, but shows significant histone methyltransferase activity against nucleosomes. [provided by RefSeq, Aug 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -15 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.36).
BP6
Variant 19-2191212-C-T is Benign according to our data. Variant chr19-2191212-C-T is described in ClinVar as [Benign]. Clinvar id is 777359.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.937 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 4 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DOT1L | NM_032482.3 | c.465C>T | p.Asp155= | synonymous_variant | 5/28 | ENST00000398665.8 | NP_115871.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DOT1L | ENST00000398665.8 | c.465C>T | p.Asp155= | synonymous_variant | 5/28 | 1 | NM_032482.3 | ENSP00000381657 | P2 | |
DOT1L | ENST00000686010.1 | c.465C>T | p.Asp155= | synonymous_variant | 5/28 | ENSP00000510335 | A2 | |||
DOT1L | ENST00000452696.5 | c.393C>T | p.Asp131= | synonymous_variant | 5/8 | 3 | ENSP00000404284 | |||
DOT1L | ENST00000478937.3 | c.*336C>T | 3_prime_UTR_variant, NMD_transcript_variant | 6/6 | 3 | ENSP00000484015 |
Frequencies
GnomAD3 genomes AF: 0.00377 AC: 574AN: 152084Hom.: 4 Cov.: 31
GnomAD3 genomes
AF:
AC:
574
AN:
152084
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000895 AC: 223AN: 249090Hom.: 0 AF XY: 0.000651 AC XY: 88AN XY: 135172
GnomAD3 exomes
AF:
AC:
223
AN:
249090
Hom.:
AF XY:
AC XY:
88
AN XY:
135172
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000426 AC: 623AN: 1461708Hom.: 5 Cov.: 32 AF XY: 0.000364 AC XY: 265AN XY: 727152
GnomAD4 exome
AF:
AC:
623
AN:
1461708
Hom.:
Cov.:
32
AF XY:
AC XY:
265
AN XY:
727152
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00380 AC: 578AN: 152202Hom.: 4 Cov.: 31 AF XY: 0.00356 AC XY: 265AN XY: 74412
GnomAD4 genome
AF:
AC:
578
AN:
152202
Hom.:
Cov.:
31
AF XY:
AC XY:
265
AN XY:
74412
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 28, 2017 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at